The FirstTake Podcast – 23 September 2021

In this episode, FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King share their post-ESMO thoughts on exciting new clinical data in HER2-positive breast cancer, further emergence of the KRAS inhibitors into colorectal cancer and multiple developments in the field of gastric cancer.

Please subscribe, like and share and most importantly, thanks for listening.

Listen on Apple podcastsSpotify or Google

To read more ViewPoints articles, click here.

Reference Articles